Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,313 | -261 | 8,362 | 6,717 | N/A |
| Depreciation Amortization | 1,822 | 1,193 | 960 | 1,147 | N/A |
| Accounts receivable | -931 | 42 | 1,352 | 12,551 | N/A |
| Accounts payable and accrued liabilities | -1,500 | -570 | -7,312 | -10,271 | N/A |
| Other Working Capital | 488 | -16,592 | -16,591 | -1,995 | N/A |
| Other Operating Activity | 5,675 | 2,016 | 6,647 | -1,392 | 0 |
| Operating Cash Flow | $-32,759 | $-14,172 | $-6,582 | $6,757 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,572 | -2,961 | -940 | -500 | N/A |
| Investing Cash Flow | $-3,572 | $-2,961 | $-940 | $-500 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 77,460 | 85,871 | 47 | 70 | N/A |
| Common Stock Repurchased | -19 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 12,015 | 0 |
| Financing Cash Flow | $77,441 | $85,871 | $47 | $12,085 | $N/A |
| Beginning Cash Position | 116,481 | 47,743 | 55,218 | 36,876 | N/A |
| End Cash Position | 157,591 | 116,481 | 47,743 | 55,218 | N/A |
| Net Cash Flow | $41,110 | $68,738 | $-7,475 | $18,342 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,759 | -14,172 | -6,582 | 6,757 | N/A |
| Capital Expenditure | -3,572 | -2,961 | -940 | -500 | N/A |
| Free Cash Flow | -36,331 | -17,133 | -7,522 | 6,257 | 0 |